Admission of new ordinary sha
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.
16 September 2010
QUEEN'S WALK INVESTMENT LIMITED
ADMISSION OF NEW ORDINARY SHARES
Further to the announcements regarding its proposed Placing and Open Offer and subsequent Bonus Issue of Preference Shares, the Company confirms that the 13,322,328 New Ordinary Shares offered under the Placing and Open Offer will be admitted to trading on the main market of the London Stock Exchange at 8.00 a.m. today.
The total number of voting rights as at 16 September 2010 will increase to 39,966,985. This figure can be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FSA's Disclosure and Transparency Rules.
Terms set out in this announcement but not defined are as defined in the Prospectus dated 17 August 2010.
-ENDS-
For further information:
|
Investor Relations Natalie Withers Tel: +44 (0)20 7968 7348
|
|
|
M: Communications Caroline Villiers Tel: +44 (0)20 7920 2321 Mob: +44 (0)78 0858 5184
James Wallis Tel: +44 (0)20 7920 2329 Mob: +44 (0)77 7555 6000
|
|
|
Liberum Capital (Sponsor, Financial Adviser and Bookrunner) Chris Bowman / Tom Fyson / Richard Bootle Tel: +44 (0)20 3100 2000 |
|
The securities described in this document have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or under any securities laws of any state or other jurisdiction of the United States or under the securities laws of Australia, Canada, Japan or South Africa. Consequently, such securities may not be offered, sold, resold, taken up, exercised, renounced, transferred delivered or distributed, directly or indirectly, into or within the United States or to, or for the account or benefit of, US Persons. No public offering of the securities is being made in the United States. The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "US Investment Company Act") and, as such, investors will not be entitled to the benefits of the US Investment Company Act. No offer, purchase, sale, exercise or transfer of the securities may be made except under circumstances which will not result in the Company being required to register as an investment company under the US Investment Company Act.
The release, publication or distribution of this document into jurisdictions other than the United Kingdom may be restricted by law. Persons to whom this document is made available should, therefore, inform themselves about and observe any such restrictions. No action has been taken by the Company that would permit the offer or sale of any securities or possession or distribution of this document in any jurisdiction where action for that purpose is required. Any failure to comply with such restrictions may constitute a violation of the laws of such jurisdictions.
This information is provided by RNS
Latest directors dealings
- 14 minutes ago City of London Investment Group
- 21 minutes ago BioPharma Credit
- 25 minutes ago BioPharma Credit
- 26 minutes ago Diageo
- 30 minutes ago Barr (A.G.)